Literature DB >> 25424605

Genetic association between IL-27 rs153109 polymorphism and cancer risk in Chinese population: a meta-analysis.

Xiu-Peng Xu1, Ling-Yang Hua1, Hong-Lu Chao1, Zheng-Xin Chen1, Xie-Feng Wang1, Jing Ji1, Ning Liu1.   

Abstract

IL-27 plays an important role in anti-cancer activity. The -964A/G polymorphism in IL-27 gene has been implicated in susceptibility to cancer, but the results were conflicting. The aim of this study was to assess the association between this polymorphism and cancer risk. Pubmed and Wanfang database were searched for all publications concerning IL-27 -964A/G polymorphism and cancer risk. Odds ratio (OR) and 95% confidence interval (CI) were used to assess the strength of association. Statistical analysis was performed using Stata 11.0 software. A total of eight case-control studies including 2044 cancer cases and 2197 controls were identified. Overall, significant association between IL-27 -964A/G polymorphism and cancer risk was observed (GG versus AA: OR = 1.26, 95% CI = 1.03-1.52; GG versus AG + AA: OR = 1.20, 95% CI = 1.00-1.44). In subgroup analysis based on cancer type, significant association was found in colorectal cancer (GG versus AA: OR = 1.55, 95% CI = 1.07-2.27; AG versus AA: OR = 1.31, 95% CI = 1.02-1.67). The current meta-analysis suggests that IL-27 -964A/G polymorphism might enhance cancer risk. However, large-scale and well-designed studies are still needed to confirm the result of our meta-analysis. The association of IL-27 polymorphism with colorectal cancer may provide insight for future therapies.

Entities:  

Keywords:  Cancer; IL-27; gene polymorphism; meta-analysis; rs153109

Mesh:

Substances:

Year:  2017        PMID: 25424605     DOI: 10.3109/10799893.2014.986743

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  5 in total

Review 1.  Interleukin-27 as a Novel Therapy for Inflammatory Bowel Disease: A Critical Review of the Literature.

Authors:  Caroline Andrews; Mairi H McLean; Scott K Durum
Journal:  Inflamm Bowel Dis       Date:  2016-09       Impact factor: 5.325

2.  Association of IL-27 rs153109 and rs17855750 Polymorphisms with Risk and Response to Therapy in Acute Lymphoblastic Leukemia.

Authors:  Alireza Ghavami; Gholamreza Fathpour; Zahra Amirghofran
Journal:  Pathol Oncol Res       Date:  2017-08-21       Impact factor: 3.201

3.  Association of 3 Common Polymorphisms of IL-27 Gene with Susceptibility to Cancer in Chinese: Evidence From an Updated Meta-Analysis of 27 Studies.

Authors:  Meng Zhang; Xiuxiu Tan; Junjie Huang; Zekai Ke; Yukun Ge; Hu Xiong; Wei Lu; Lu Fang; Zhiming Cai; Song Wu
Journal:  Med Sci Monit       Date:  2015-08-24

4.  Polymorphisms and plasma levels of IL-27: impact on genetic susceptibility and clinical outcome of bladder cancer.

Authors:  Bin Zhou; Peng Zhang; Tielong Tang; Hong Liao; Kui Zhang; Yan Pu; Peng Chen; Yaping Song; Lin Zhang
Journal:  BMC Cancer       Date:  2015-05-27       Impact factor: 4.430

5.  A preliminary study of cytokine gene polymorphism effects on Saudi patients with colorectal cancer.

Authors:  Sarah A Althubyani; Afrah F Alkhuriji; Suliman Y Al Omar; Manal F El-Khadragy
Journal:  Saudi Med J       Date:  2020-12       Impact factor: 1.484

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.